In particular, we used Kaplan-Meier survival analysis and the log-rank test to examine whether PSMC2 expression was correlated with overall survival (OS) and disease-free survival (DFS) for HCC patients (Figure 1C). This evidence concerns the gene PSMC2 and hepatocellular carcinoma.